Cara Therapeutics Inc (CARA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4 STAMFORD PLAZA STAMFORD, CT 06902

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Data based on most recent fiscal year report
Market Cap675.306 Million Shares Outstanding40.03 Million Avg Volume968.5 Thousand
1-Yr BETA vs S&P TR1.209 Current Ratio4.16 Quick Ratio4.16
View SEC Filings from CARA instead.

View recent insider trading info

Funds Holding CARA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CARA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

2.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

2.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

IVES JEFFREY L.

  • Director
6,000 2020-03-04 10

MENZAGHI FREDERIQUE PH.D. CHIEF SCIENTIFIC OFF,SVP-R&D

  • Officer
79,886 2020-02-24 10

CHALMERS DEREK T PRESIDENT & CEO

  • Officer
  • Director
967,769 2020-02-24 8

TERRILLION SCOTT SEC'Y; CHIEF COMPLIANCE & G.C.

  • Officer
32,769 2020-02-24 3

GONCALVES JOANA CHIEF MEDICAL OFFICER

  • Officer
16,000 2020-02-24 1

MAKARA RICHARD VP, HEAD OF ACCTING;CONTROLLER

  • Officer
0 2020-02-24 2

MOHINDRU MANI CFO & CHIEF STRATEGY OFFICER

  • Officer
17,441 2019-12-02 3

BAINS HARRISON M JR

  • Director
6,000 2019-06-04 1

VOGELBAUM MARTIN

  • Director
6,000 2019-06-04 2

POSNER CHRISTOPHER

  • Director
6,000 2019-06-04 1

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

SCHOELL JOSEF CHIEF FINANCIAL OFFICER

  • Officer
50,000 2017-07-26 0

SLAGEL DEAN

  • Director
1,064,338 2017-06-29 0

RHO VENTURES VI LP

RMV VI, L.L.C.

RHO CAPITAL PARTNERS LLC

LESCHLY MARK

KAIROUZ HABIB

RUCH JOSHUA

  • 10% Owner
3,568,057 2017-03-31 0

LEWIS MICHAEL E CHIEF SCIENTIFIC ADVISOR

  • Officer
0 2017-03-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

IVES JEFFREY L. - Director

2020-03-04 M 2,500 d 6,000 6,000.00 direct yes

IVES JEFFREY L. - Director

2020-03-04 S 2,500 $16.00 d 6,000 6,000.00 direct yes

IVES JEFFREY L. - Director

2020-03-04 M 2,500 $9.94 a 8,500 6,000.00 direct yes

TERRILLION SCOTT - Officer SEC'Y; CHIEF COMPLIANCE & G.C.

2020-02-24 A 16,000 a 32,769 32,769.00 direct

MAKARA RICHARD - Officer VP, HEAD OF ACCTING;CONTROLLER

2020-02-24 A 30,000 a 30,000 0.00 direct

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2020-02-24 A 100,000 a 100,000 967,769.00 direct

GONCALVES JOANA - Officer CHIEF MEDICAL OFFICER

2020-02-24 A 16,000 a 16,000 16,000.00 direct

MENZAGHI FREDERIQUE PH.D. - Officer CHIEF SCIENTIFIC OFF,SVP-R&D

2020-02-24 A 32,000 a 32,000 79,886.00 direct

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2020-02-24 A 50,000 a 967,769 967,769.00 direct

TERRILLION SCOTT - Officer SEC'Y; CHIEF COMPLIANCE & G.C.

2020-02-24 A 32,000 a 32,000 32,769.00 direct

MENZAGHI FREDERIQUE PH.D. - Officer CHIEF SCIENTIFIC OFF,SVP-R&D

2020-02-24 A 16,000 a 79,886 79,886.00 direct

GONCALVES JOANA - Officer CHIEF MEDICAL OFFICER

2020-02-24 A 32,000 a 32,000 16,000.00 direct

Elevate your investments